Star Health & Allied Insurance Company Share Price Target 2025, 2026 to 2030

Star Health & Allied Insurance Company Ltd, established in 2006 and headquartered in Chennai, Tamil Nadu, is a prominent player in the Indian health insurance industry. Under the leadership of V. Jagannathan (MD & CEO) and S. S. Mallikarjuna Rao (Chairman), the company operates with the stock symbol STARHEALTH and ISIN INE058A01015. Specializing in health insurance, Star Health offers a diverse range of products, including medical, personal accident, and travel insurance, catering to individuals, families, senior citizens, and corporate clients. Their plans provide comprehensive coverage for medical expenses, critical illnesses, and maternity, ensuring tailored solutions for various customer needs. The company supports its services through a robust network of over 14,000 hospitals across India, offering cashless treatment options, and a dedicated 24×7 multilingual call center for claims assistance and customer support. Star Health upholds values of quality, customer satisfaction, and innovation, investing in technology to enhance services while emphasizing sustainability and community well-being.

Latest news on Star Health & Allied Insurance Company

On December 23, 2024, shares of Star Health & Allied Insurance Company Ltd witnessed a significant decline of up to 8.4%, following the GST Council’s decision to defer discussions on reducing GST rates for life and health insurance premiums. This delay has created uncertainty in the market, impacting investor sentiment. The council’s decision on the matter is anticipated to be revisited in January 2025, leaving industry stakeholders and investors awaiting clarity on potential regulatory changes.

Shareholdings patterns of Star Health & Allied Insurance Company

Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Promoters + 58.01% 57.94% 57.92% 57.90% 57.70%
FIIs + 30.63% 31.01% 26.57% 21.58% 17.65%
DIIs + 6.11% 6.11% 11.14% 15.10% 17.05%
Public + 5.23% 4.96% 4.38% 5.40% 7.60%
No. of Shareholders 1,71,423 1,83,343 1,75,298 1,89,347 1,96,778

The shareholding pattern of Star Health & Allied Insurance Company reflects notable trends over recent quarters, showcasing shifts among key investor categories. As of September 2023, promoters held a majority stake of 58.01%, which gradually decreased to 57.70% by September 2024. Foreign Institutional Investors (FIIs) also reduced their holdings significantly from 30.63% in September 2023 to 17.65% in September 2024, indicating a sharp decline in their investment.

Conversely, Domestic Institutional Investors (DIIs) increased their stake substantially, rising from 6.11% in September 2023 to 17.05% by September 2024, demonstrating heightened interest from domestic investors. The public shareholding also grew during the period, climbing from 5.23% to 7.60%. Additionally, the number of shareholders increased steadily, from 1,71,423 in September 2023 to 1,96,778 by September 2024, reflecting a broader participation from retail investors. These trends highlight a dynamic redistribution of ownership in Star Health & Allied Insurance Company over the analyzed quarters.

How To Purchase Star Health & Allied Insurance Company Shares?

Below are the trading platforms that you can use to purchase Star Health & Allied Insurance Company shares:

➤ Zerodha

➤ Upstox

➤ Groww

➤ AngelOne

Finances rule

➤ ICICIDirect

Star Health & Allied Insurance Company Share Price Target: 2025, 2026 to 2030

Star Health & Allied Insurance Company Share Price Prediction 2025

When Maximum Price Minimum Price
January 2025 527.05 405.43
February 2025 532.38 409.52
March 2025 543.56 418.12
April 2025 538.18 413.98
May 2025 522.50 401.92
June 2025 546.01 420.01
July 2025 535.31 411.77
August 2025 551.86 424.51
September 2025 558.49 429.60
October 2025 573.01 440.77
November 2025 587.33 451.79
December 2025 613.76 472.12

As we move through 2025, the projected price trends for Star Health & Allied Insurance Company reflect a steady upward trajectory. In January, the maximum price is expected to reach ₹527.05, with a minimum of ₹405.43. By December, these figures are anticipated to rise significantly, with the maximum price projected at ₹613.76 and the minimum at ₹472.12.

Star Health & Allied Insurance Company Share Price Target 2026

When Maximum Price Minimum Price
January 2026 632.17 486.29
February 2026 616.37 474.13
March 2026 628.70 483.61
April 2026 641.53 493.48
May 2026 635.18 488.60
June 2026 651.06 500.81
July 2026 638.29 490.99
August 2026 658.03 506.18
September 2026 671.19 516.30
October 2026 688.64 529.72
November 2026 705.86 542.97
December 2026 723.50 556.54

As we step into 2026, the price projections for Star Health & Allied Insurance Company indicate continued growth. In January, the maximum price is expected to reach ₹632.17, with a minimum of ₹486.29. By December, these values are projected to climb further, with the maximum price anticipated at ₹723.50 and the minimum at ₹556.54.

Star Health & Allied Insurance Company Share Price Target 2027

When Maximum Price Minimum Price
January 2027 730.74 562.11
February 2027 749.48 576.52
March 2027 778.71 599.00
April 2027 763.44 587.26
May 2027 741.20 570.15
June 2027 774.56 595.81
July 2027 759.37 584.13
August 2027 782.85 602.20
September 2027 810.25 623.27
October 2027 831.32 639.48
November 2027 852.10 655.46
December 2027 873.41 671.85

Star Health & Allied Insurance Company Share Price Prediction 2028

When Maximum Price Minimum Price
January 2028 890.87 685.29
February 2028 913.72 702.86
March 2028 949.35 730.27
April 2028 930.74 715.95
May 2028 903.63 695.10
June 2028 944.29 726.38
July 2028 925.78 712.14
August 2028 954.41 734.16
September 2028 987.81 759.86
October 2028 1,013.50 779.61
November 2028 1,038.83 799.10
December 2028 1,064.80 819.08

Star Health & Allied Insurance Company Share Price Target 2029

When Maximum Price Minimum Price
January 2029 1,086.10 835.46
February 2029 1,113.95 856.88
March 2029 1,157.39 890.30
April 2029 1,134.70 872.84
May 2029 1,101.65 847.42
June 2029 1,151.22 885.56
July 2029 1,128.65 868.19
August 2029 1,163.56 895.04
September 2029 1,204.28 926.37
October 2029 1,235.59 950.46
November 2029 1,266.48 974.22
December 2029 1,298.14 998.57

Star Health & Allied Insurance Company Share Price Prediction 2030

When Maximum Price Minimum Price
January 2030 1,324.11 1,018.54
February 2030 1,358.06 1,044.66
March 2030 1,411.02 1,085.40
April 2030 1,383.36 1,064.12
May 2030 1,343.06 1,033.13
June 2030 1,403.50 1,079.62
July 2030 1,375.98 1,058.45
August 2030 1,418.54 1,091.18
September 2030 1,468.19 1,129.37
October 2030 1,506.36 1,158.74
November 2030 1,544.02 1,187.71
December 2030 1,582.62 1,217.40

In 2030, the stock performance of Star Health & Allied Insurance Company is projected to demonstrate significant growth throughout the year. As we begin in January, the maximum price is expected to reach ₹1,324.11, with a minimum of ₹1,018.54. By December, the projections indicate further advancements, with the maximum price anticipated at ₹1,582.62 and the minimum at ₹1,217.40, reflecting a positive trajectory for the company’s stock value over the year.

Financial Condition of Star Health & Allied Insurance Company

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
Sales + 4,987 5,050 10,602 12,096 14,022 15,141
Expenses + 4,544 6,447 11,962 11,223 12,839 13,996
Operating Profit 443 -1,397 -1,360 873 1,184 1,145
OPM % 9% -28% -13% 7% 8% 8%
Other Income + 0 -3 7 5 4 7
Interest 0 0 0 0 0 0
Depreciation 29 46 43 52 59 0
Profit before tax 413 -1,446 -1,397 826 1,129 1,152
Tax % 35% -25% -25% 25% 25%
Net Profit + 268 -1,086 -1,041 619 845 862
EPS in Rs 5.46 -19.81 -18.08 10.63 14.44 14.72
Dividend Payout % 0% 0% 0% 0% 0%

The financial performance of Star Health & Allied Insurance Company has shown significant evolution over the years, with notable improvements in recent periods. Sales steadily grew from ₹4,987 crore in March 2020 to ₹14,022 crore in March 2024, demonstrating a strong growth trajectory, further extending to ₹15,141 crore in the trailing twelve months (TTM). Correspondingly, expenses increased from ₹4,544 crore in March 2020 to ₹12,839 crore in March 2024, with TTM expenses reaching ₹13,996 crore.

Operating profit exhibited a recovery after consecutive losses, moving from ₹-1,360 crore in March 2022 to ₹873 crore in March 2023 and ₹1,184 crore in March 2024, with the Operating Profit Margin (OPM) improving to 8% in the latest periods. The net profit followed a similar trend, recovering from ₹-1,086 crore in March 2021 to ₹845 crore in March 2024, supported by consistent tax adjustments and improved operational efficiencies.

Earnings Per Share (EPS) reflected this recovery, increasing from a low of ₹-19.81 in March 2021 to ₹14.44 in March 2024 and ₹14.72 in the TTM. However, Star Health & Allied Insurance Company maintained a 0% dividend payout ratio throughout the analyzed period, likely focusing on reinvestment and business expansion.

FAQs

What is Star Health & Allied Insurance Company’s current market capitalization?

Star Health & Allied Insurance Company’s market capitalization is 28,041 crore.

What is Star Health & Allied Insurance Company’s current share price target for 2025?

The share price target for Star Health & Allied Insurance Company in January 2025 is ₹527.05.

What is the projected share price target for Star Health & Allied Insurance Company in 2026?

Star Health & Allied Insurance Company’s share price target for December 2026 is ₹723.50.

What is the share price target for Star Health & Allied Insurance Company in 2030?

Star Health & Allied Insurance Company’s projected maximum share price target for December 2030 is ₹1,582.62.

What is Star Health & Allied Insurance Company’s current stock P/E ratio?

Star Health & Allied Insurance Company’s stock P/E ratio is 32.5.

Also Read

Conclusion

In conclusion, Star Health & Allied Insurance Company Ltd has demonstrated a resilient market presence and growth potential in the Indian health insurance industry. Despite facing challenges such as regulatory uncertainties and shifts in shareholding patterns, the company has continued to strengthen its position through innovative offerings, robust infrastructure, and customer-centric strategies. Financially, the firm has shown significant improvement in profitability metrics over recent years, supported by rising sales and controlled expenses.

The projected share price trajectory for 2025 to 2030 reflects sustained growth, driven by increasing investor confidence and market expansion. With strategic leadership and a focus on technological advancement and customer satisfaction, Star Health remains well-positioned for long-term success in the competitive health insurance sector.

Financesrule telegram

Author: Ashnoor

Leave a Reply